Travere Therapeutics Inc
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Trading Arrangements
During the fiscal quarter ended September 30, 2024, our directors and/or officers (as defined in Rule 16a-1(f) under the Exchange Act)adopted, modified orterminated the “Rule 10b5-1 trading arrangements” or “non-Rule 10b5-1 trading arrangements,” as those terms are defined in Regulation S-K, Item 408, set forth below:
Trading Arrangements Adopted:
| Name & Title | Date Adopted | Character of Trading Arrangement (1) | Aggregate Number of Shares of Common Stock to be Sold Pursuant to Trading Arrangement | Expiration Date (2) |
|---|---|---|---|---|
| Roy D. Baynes,member of our Board of Directors | August 16, 2024 | Rule 10b5-1 Trading Arrangement | Up to 26,000 shares (3) | October 31, 2025 |
| Sandra Calvin,SVP and Chief Accounting Officer | September 9, 2024 | Rule 10b5-1 Trading Arrangement | Up to 86,187 shares (4) | September 9, 2025 |
| 1 | Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act (the “Rule”). |
| 2 | Each trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales and (b) the date listed in the table. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule. |
| 3 | Consists of shares of underlying stock options expiring in 2026 and 2027. |
| 4 | Includes shares underlying stock options expiring in January 2025. |
Trading Arrangements Modified or Terminated:
None.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.